Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma [1]

Journal of Clinical Pathology

Volumn 60, Issue 8, 2007, Pages 958-

  Altundag, Kadri ^a   Dede, Didem S ^a   Purnak, Tugrul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CASTOR OIL; CAVEOLIN 1; NANOPARTICLE; PACLITAXEL;

ANGIOGENESIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; HUMAN; LETTER; LIPOPHILICITY; MOLECULAR WEIGHT; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; TRANSCYTOSIS; TREATMENT RESPONSE;

ALBUMINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CAVEOLIN 1; FEMALE; HUMANS; PACLITAXEL;

EID: 34547746905     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.042481     Document Type: Letter

References (5)

1. Banerjee S, Reis-Filho JS, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 2006;59:729-35.
2. Pinilla SM, Honrado E, Hardisson D, et al. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat 2006;99:85-90.
3. Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005;11:5678-85.
4. Gradishar WJ, Tjulandin S, Davidson N, et al. Superior efficacy of albumin-bound paclitaxel, ABI-007, compared with polyethylated castor oil-based paclitaxel in women with metastatic breast cancer: results of a phase III trial. J Clin Oncol 2005;23:7794-803.
5. Desai N, Yao Z, Trieu V, et al. Evidence of greater antitumor activity of Cremophor-free nanoparticle albumin-bound (nab) paclitaxel (Abraxane) compared to Taxol: role of a novel albumin transporter mechanism. Presented at the 26th Annual San Antonio Breast Cancer Symposium; San Antonio, TX, December, 2003:3-6.